Dialysis is treatment technique to compensate the poor or lost kidney function. The kidney function is damaged by acute kidney injury or chronic kidney disease. The most common reasons for kidney diseases are urinary infection, diabetes, and genetic kidney diseases. Dialysis equipment and accessories are used for artificial blood purification in end stage of renal disease as well as acute kidney injury in dialysis centers or in homecare settings. Dialysis treatment offers a solution to kidney impairment by artificially filtering the blood. The dialysis process regulates water and salts to clean the blood. Patients with kidney failure need dialysis in order to sustain life. There are two forms of dialysis treatment namely peritoneal dialysis (PD) and haemodialysis (HD).
Hemodialysis is commonly used dialysis technology that treats circulating blood in the dialysis machine. Blood is cleaned as it passes through a dialyzer to diffuse the waste products in dialysis concentrate. The peritoneal dialysis is a technique in which the dialysis fluid is transferred into peritoneal cavity through a catheter in the peritoneum and abdomen to function as a dialysis filter in a dialyzer.
Factors such as increasing number of patients suffering from hypertension and diabetes and the growing number of end stage renal disease in patients have been driving the growth of the global dialysis device and concentrates market. In addition, factors such as technological advancements in products, negligible preference of patients for kidney transplantation, increase in investment for the development of new products and reimbursement from governments for the treatment of kidney diseases and end-stage renal disease are further expected to propel the growth of the global dialysis and concentrates market. However, factors such as product recalls, lower awareness of kidney diseases treatment modalities and low adoption of newly developed devices could hamper the growth of the global dialysis and concentrates market.
The global dialysis device and concentrates market in developed countries is increasing in terms of revenue at a rapid pace owing to factors such as increasing number of dialysis centers, improving reimbursement and insurance scenario, the huge patient population base, and government initiatives to develop dialysis facilities which are anticipated to drive the growth of the global dialysis device and concentrates market during 2016-2026.
Request For Report sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2553
Some of the key players in global dialysis device and concentrates market include Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, DaVita Healthcare Partners, Inc., Nipro Corporation, Asahi Kasei Medical Co. Ltd., Mar Cor Purification, Inc., Nikkiso Co, Ltd., NxStage Medical, Inc.,and others. Most of the providers of dialysis device and concentrates are adopting the strategy of providing these products in emerging countries and the other untapped market.